Heart failure triggers multimorbidity by altering stem cells, study reveals

FHS
May 28, 2024
5:16 am

Researchers identified that heart failure (HF) promotes multimorbidity by altering hematopoietic stem cells (HSCs) to produce pro-inflammatory macrophages, increasing vulnerability in multiple organs. The study highlights the role of suppressed TGF-β signaling in these alterations, contributing to chronic inflammation and subsequent health issues.

NMA reveals Vabysmo’s superior CST improvement over Eylea HD

On 21 October 2024, at the 128th Annual Meeting of the American Academy of Ophthalmology (AAO) 2024 in Chicago, US, a matching-adjusted meta-analysis that indirectly

October 23, 2024

Guardant accuses Natera of poaching employees, stealing trade secrets

Dive Brief: Guardant Health has accused Natera of poaching its employees and stealing its trade secrets in a lawsuit filed Thursday. The lawsuit claims Natera aggressively

February 24, 2025

GE HealthCare Receives FDA Clearance for SIGNA™ MAGNUS Head-Only MRI Scanner

What You Should Know: – GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI)

November 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.